Jatropha Leaf Extract as an Anti-Glycation Cosmeceutical Hydrogel: A Review of the Evidence, Rationale and Formulation Prospects

Sagar Vaidya; Aniket Chavan; Ankush Khanjode; Gayatri Jadhav; Manish Ahire; Shital Chavan

doi:10.5281/zenodo.23876654

Review Paper | Open Access
Volume 04 | Issue 11 | Article Id IJPS/260410552

Jatropha Leaf Extract as an Anti-Glycation Cosmeceutical Hydrogel: A Review of the Evidence, Rationale and Formulation Prospects
Sagar Vaidya* Aniket Chavan* Ankush Khanjode Gayatri Jadhav Manish Ahire Shital Chavan
JES SND institute of pharmacy Babhulgaon Yeola -423401.

Abstract

The non-enzymatic reaction between reducing sugars (or the products of their reactive carbonyl breakdown) and proteins, lipids, or nucleic acids is known as glycation. AGEs, or advanced glycation end products, are produced by it. Long-lasting dermal proteins in the skin, such collagen and elastin, accumulate AGEs. Cross-linking, rigidity, yellowing, and elasticity loss result from this. Additionally, AGEs trigger the receptor for AGEs (RAGE), which increases inflammation and oxidative stress [1,2]. As a result, anti-glycation actives are becoming more and more popular as cosmetic additives. Since the reference inhibitor, aminoguanidine, has not been used in clinical settings [1], plant-derived polyphenols and flavonoids are being investigated as potential substitutes [10–12]. In traditional medicine, plants in the genus Jatropha (Euphorbiaceae) are frequently used to treat wounds, inflammation, and skin conditions. Vitexin and isovitexin, two C-substances prevent the production of AGEs [14–16]. The literature on (i) skin glycation and anti-glycation tactics, (ii) plant-based anti-glycation evidence and assay techniques, (iii) Jatropha leaf phytochemistry, antioxidant, anti-inflammatory, and wound-healing activity, (iv) current Jatropha topical gels, and (v) hydrogels as cosmeceutical carriers is compiled in this review. Glycosylflavones are one of the flavonoids present in their leaves, and an ion framework is suggested for further studies. In different plant systems, these.

Keywords

Jatropha, advanced glycation end-products, anti-glycation, skin ageing, cosmeceutical, hydrogel, vitexin, isovitexin, flavonoids

Introduction

Both extrinsic (UV radiation, pollution, smoking, diet) and internal (genetics, chronological ageing) factors contribute to skin ageing. Because they result from both internal metabolism and external exposures, AGEs are regarded as a "mixed" component [1]. Glycation is significantly increased in diabetes and increases with age, high-carb diets, and UV exposure [1]. Over the past ten years, interest in "anti-AGE" cosmeceuticals has increased. Glycation is a major but little-known cause of cutaneous ageing, according to a narrative review published in the Journal of Cosmetic Dermatology [4]. It also points out that there is still no clinical data supporting various anti-glycation treatments. Initial evaluations had Early reviews had already highlighted the pharmaceutical industry's interest in anti-AGE strategies for new anti-ageing cosmeceutical compounds [3].

Antioxidants and phenolics, which frequently exhibit anti-glycation activity, are abundant in medicinal plants [10,11]. About 170 species in the genus Jatropha are used in traditional medicine to treat ailments such skin disorders, ulcers, and inflammation [21]. Jatropha has not been investigated as an anti-glycation drug despite this ethnomedical characteristics. This review's objective is to determine whether the available data warrants the creation of a hydrogel made from Jatropha leaf extract for this use.

Figure 1: Image of Jatropha Curcas Plant

Table 1: Taxonomical Classification

Kingdom:	Plantae
Sub - Kingdom	Tracheophytes
Class	Angiosperms
Clade	Eudicots
Sub-Clade	Rosids
Order	Malpighiales
Family	Euphorviaceae
Genus	Jatropha
Species	J. curcas
Biological name	Jatropha curcas
Marathi name	Mogali

2. Glycation and the Skin

2.1 Chemistry of AGE formation

Schiff bases are created when free amino groups combine with reducing carbohydrates like fructose and glucose. These reorganise into Amadori and Heyns products, which are early glycation products. These compounds undergo oxidative degradation, producing reactive dicarbonyls (glyoxal, methylglyoxal, and 3-deoxyglucosone) that propel the production of AGEs [1,5]. AGEs consist of:

Intermediate products such as N^ε^-(carboxymethyl)lysine (CML) and carboxyethyl-lysine;
late products such as MG-H1, argpyrimidine, pentosidine and glucosepane [1].

The most common AGE discovered in vivo is said to be CML [11]. Since oxidation and glycation are closely related, many antioxidants may theoretically also lessen glycation stress [1].

2.2 Consequences in skin

Matrix cross-linking. AGEs accumulate in collagen and elastin and increase cross-linking, tissue stiffness and loss of elasticity [4].
RAGE signalling. RAGE is highly expressed in skin [1,8]. AGE–RAGE binding triggers reactive oxygen species (ROS) generation and inflammatory signalling. In fibroblast models this leads to higher MMP expression, lower collagen expression, and cell senescence or death [1,2].
UV interaction. AGEs generate active oxygen species under UVA irradiation [9], linking glycation to photo-ageing
Changes are visible. The surface grows rougher and the skin turns darker and yellower. Wrinkles deepen and the dermis gets thinner and tougher [1].

2.3 Strategies against glycation-induced skin ageing

Choi et al. outline five strategies [1]:

1. stop the creation of new AGEs (glycation inhibitors, dicarbonyl scavengers, antioxidants);

2. eliminate existing AGEs (AGE breakers, deglycating enzymes);

3. regulate RAGE-mediated signalling; 4. bolster cellular antioxidant defences;

5. restore cells and matrix.

The typical positive control in laboratory research is aminoguanidine. Because of worries about the safety/efficacy balance, it is not used in clinical settings. There are also restrictions on the AGE-breaker alagebrium (ALT-711) and similar substances [1]. Rutin, quercetin, apigenin, rosmarinic acid, ferulic acid, and chlorogenic acid are examples of natural phenolics that have been thoroughly investigated as glycation inhibitors with possible anti-aging effects on the skin [1].

Numerous topical treatments containing anti-glycation or antioxidant agents have shown beneficial in clinical settings. A gel cream with Dunaliella salina extract, a lotion with Cirsium japonicum flower extract, a serum with sunflower sprout extract, and an essence with supramolecular carnosine are a few examples. In certain instances, this decreased skin AGE levels and enhanced skin-aging metrics [1]. Nevertheless, there are still few clinical trials, and it is challenging to compare natural products directly [1].

2.4 Standard in vitro methods for screening anti-glycation activity

Table 2: Standard in vitro Methods for Screening Anti-Glycation Activity

Parameter	Typical approach	Ref.
Model protein	Bovine serum albumin (BSA), or collagen/elastin for skin relevance	[1]
Glycating agent	Glucose, fructose, ribose, glyoxal, methylglyoxal (MGO)	[1,19]
Conditions	pH 7.4, 37 °C, days to weeks; sodium azide added to prevent microbial growth	[1]
Readouts	Fluorescent AGEs; NBT assay; ELISA/CML; SDS-PAGE; fructosamine; protein carbonyls and thiols	[1,19]
Positive control	Aminoguanidine	[1,19]
Cell/skin models	Human dermal fibroblasts, reconstructed skin, skin explants	[1]

An important caution is that the same compound can behave differently depending on the sugar used to induce glycation. Sadowska-Bartosz et al. tested 25 natural compounds against BSA glycoxidation by glucose, fructose and ribose. They found differing effects across sugars and advised caution in extrapolating from a single-sugar model [12]. Screening should therefore use more than one glycating system.

3. Plant-Derived Anti-Glycation Agents

Searches for glycation inhibitors, particularly in vitro, have frequently identified polyphenols and other natural antioxidants as effective [11]. Plants rich in phenolics and triterpenoids commonly demonstrate combination antioxidant and anti-glycation properties [10]. A study of medicinal plant extracts indicated that suppression of AGE production linked with phenolic content and antioxidant activity [13]. Selected evidence relevant to a Jatropha leaf product is summarised below.

Table 3: Selected Plant Extracts and Flavonoids with Reported Anti-Glycation Activity

Material	Key finding	Ref.
Mung bean extract; vitexin and isovitexin	Both compounds inhibited AGE formation (glucose- or MGO-induced) with efficacy above 85% at 100 µM. They did not directly trap MGO, so activity was attributed mainly to free-radical scavenging.	[14]
Mung bean water extract	Vitexin and isovitexin identified in the extract. The extract inhibited AGE formation (IC~50~ = 2.28 mg/mL).	[18]
Bamboo-leaf flavonoids (orientin, isoorientin, vitexin, isovitexin)	All four significantly reduced fluorescent AGEs and protein oxidation. Mechanisms included inhibiting protein oxidation, lowering AGE-precursor concentration and blocking dicarbonyl–protein binding.	[15]
Duchesnea chrysantha constituents	Isovitexin and several other flavonoids and ellagic acids showed excellent AGE-formation inhibition.	[16]
Flavone C-monoglucosides (orientin, homoorientin, vitexin, isovitexin)	Compared with quercetin for antioxidant, ACE-inhibitory, AChE-inhibitory and AGE-inhibitory activity in model systems.	[17]
Moringa oleifera aqueous leaf extract	Total phenolics 38.56 mg GAE/g. Dose-dependent (0.5–2.0 mg/mL) reduction of fluorescent AGEs and CML in glucose- and fructose-BSA systems, with reduced protein carbonyls. Aminoguanidine was the comparator.	[19]
Varronia curassavica ethanolic leaf extract and two isolated compounds	Significantly reduced AGE formation and protein oxidative damage in an MGO model.	[20]

This evidence is consistent with the flavone C-glycosides isovitexin and vitexin. Additionally, they are reported from Jatropha leaves (Section 4), which serves as the primary chemical foundation for the review's theory.

4. The Genus Jatropha: Botany, Phytochemistry and Relevant Bioactivities

4.1 Overview

In the seasonally dry tropics, there are roughly 170 species of trees, shrubs, subshrubs, and plants that belong to the Euphorbiaceae family. Inflammation, ulcers, skin conditions, diabetes, and oedema are among the common uses [21]. Cyclic peptides, alkaloids, diterpenes, flavonoids, phenols, lignans, and coumarins are among the substances that have been reported. Anti-inflammatory, antioxidant, antibacterial, anticoagulant, cytotoxic, and other properties are demonstrated by extracts and pure substances [21, 22]. In Africa, Asia, South America, and the Middle East, J. curcas has been utilised to treat about 100 distinct conditions [22]. There are also systematic evaluations of its toxicity and pharmacology [23].

Bellyache bush, or J. gossypiifolia, is examined independently. Its leaves are said to have insecticidal, anti-inflammatory, and antibacterial qualities; evaluations suggest little toxicity in certain in vitro and in vivo experiments [24, 25].

Figure 2: Image of Jatropha Curcas Leaves

4.2 Leaf flavonoids and antioxidant activity

Table 4: Leaf Phytochemistry and Antioxidant Data Relevant to Anti-Glycation Potential

Species / extract	Finding	Ref.
J. curcas leaves (grown in Southern Italy)	HPLC-DAD showed a flavone C-glycoside profile: vitexin most abundant, followed by vicenin-2, stellarin-2, rhoifolin, with traces of isovitexin and isorhoifolin. Extracts showed antioxidant and cytoprotective activity in lymphocytes.	[28]
J. curcas leaf ethanol extract	DPPH IC~50~ 7.47 µg/mL and ABTS IC~50~ 6.6 µg/mL. HPLC-DAD-MS^n^ tentatively identified orientin, vitexin, isovitexin and rhoifolin.	[29]
J. gossypiifolia leaf and stem methanolic extracts	Leaves had higher total phenolics (65.66 mg GAE/g) than stems (33.33 mg GAE/g). Antioxidant and membrane-stabilising activity were reported.	[30]
J. gossypiifolia leaf crude extract and aqueous fraction	Antioxidant activity including iron- and copper-chelating activity was demonstrated in vitro.	[26]
J. gossypiifolia aqueous leaf extract	Contained sugars, alkaloids, flavonoids, tannins, terpenes/steroids and proteins; showed anti-inflammatory and antiophidic effects.	[27]
J. mollissima hydroethanolic leaf extract	11 compounds characterised by LC-MS, with emphasis on flavonoids.	[32]

Metal chelation matters because transition metals catalyse the oxidative steps that convert early glycation products into AGEs (glycoxidation) [1].

4.3 Anti-inflammatory, wound-healing and antidiabetic activity

. A J. mollissima leaf-extract gel demonstrated notable wound-healing efficacy, decreased inflammatory and oxidative indices, and prevented carrageenan-induced paw oedema as well as acute and chronic croton-oil ear oedema [32].A J. variegata extract gel demonstrated wound-healing efficacy in rats and had MIC values of 0.05% against S. aureus, P. aeruginosa, and E. coli [33].At 30, 50, and 100 mg/kg, J. gossypiifolia leaf extract reduced glycaemia in streptozotocin-induced diabetic rats [31]. Diabetes is the clinical setting in which glycation is most relevant

5. Rationale for Jatropha Leaf Extract as an Anti-Glycation Agent

Note: This section is an inference from indirect evidence. It is not a report of experimental results.

Three lines of evidence support the hypothesis:

1. overlap of chemicals. Vitexin and isovitexin are found in J. curcas leaves [28, 29]. In the glucose and MGO systems, these flavonoids prevent the production of AGEs [14–16]. Extracts containing these flavones also demonstrated anti-glycation action in other plants [18]. 2. Overlap of mechanisms. Phenolic extracts lower glycoxidation by metal chelation, radical scavenging, and antioxidant action [1,14,15]. Strong radical scavenging and metal chelation are demonstrated by Jatropha leaf extracts for J. gossypiifolia [26, 29]. 3. Activities that complement the skin. Beyond glycation inhibition, cosmeceutical benefit may be enhanced by anti-inflammatory and wound-healing properties [32,33] and antibacterial activity [33,35,36]. This aligns with the "multi-target" strategy suggested for anti-aging skin care products [1].

Limitations of this reasoning.

Geographical location, species, and extraction solvent all affect the makeup of the extract. For instance, vitexin predominated in the Italian J. curcas leaves, whilst isovitexin was only detected in trace amounts [28].
Any activity of Jatropha extracts may rely on radical scavenging instead of carbonyl trapping because vitexin and isovitexin do not directly trap MGO [14].

From single-compound data, extract activity is unpredictable. It is possible for other components, such as pigments, to oppose or interfere. There are currently no experimental Jatropha anti-glycation studies available.

6. Safety Considerations

Safety is the most important consideration for any topical Jatropha product. Toxicity in the genus is mainly associated with latex and seeds. The toxins of J. curcas include phorbol esters (irritant, co-carcinogenic diterpenoids) and curcin (a ribosome-inactivating protein), and skin contact with the plant sap can cause irritation [21,22,24,37]. J. gossypiifolia has shown low toxicity in some studies, but reviews still note the toxic potential of the genus [24,25].

7. Hydrogels as Cosmeceutical Delivery Systems

Hydrogels are networks of synthetic and/or biopolymers that are cross-linked and have a high capacity to absorb water. Both biomedicine and cosmetics make extensive use of them [38, 39]. Reviews point to a number of benefits for cosmetology and dermatology: Easy application and few side effects [38], biocompatibility, particularly for natural polymers [39], suitability as bioadhesive skin-care formulations [39], and the capacity to deliver actives in a controlled manner, though delivery is dependent on skin-barrier characteristics and the physicochemical properties of the active and its carrier [3]

8. Existing Jatropha Topical Gel Studies

Table 5: Reported Jatropha Gel Formulations

Species / part	Formulation and evaluation	Main outcome	Ref.
J. mollissima hydroethanolic leaf extract	Topical gel; physicochemical characterisation; dermal irritation test; mouse inflammation, wound-healing and antiophidic models	Reduced oedema; accelerated wound healing; reduced venom-induced dermonecrosis by 55%	[32]
J. variegata methanolic leaf/stem extract	Gel tested on rats (12 female albino rats, three wounds each)	MIC 0.05% against three bacteria; wound healing superior to control (33% healed in control)	[33]
J. curcas leaf extract	Gels with 10, 15 and 20% extract on rat burns; positive control Bioplacenton	20% gel most effective; not significantly different from positive control (P > 0.05)	[34]
J. curcas leaf 70% ethanolic extract	Hand-sanitiser gel using 100 mg/mL extract; organoleptic, pH, stability and spreadability tests	Gel physically stable; inhibition zone 15.6 mm against S. aureus	[35]
J. curcas sap	Hand-sanitiser gel; best formula had 5% sap, pH 4.89, viscosity 4.60 ± 0.14 Pa·s	Homogeneous, clear whitish gel with antibacterial activity	[36]

These investigations demonstrate the ability to create stable topical gels using Jatropha extracts. It is possible to immediately adopt the evaluation criteria they employed (pH, viscosity, spreadability, homogeneity, stability, and irritation). They didn't look at glycation.

9. Proposed Development and Evaluation Framework

Note: This framework is the author's proposal built on the literature above. It is not a published protocol.

Stage 1: Extraction of plant material. Verify the species and just gather leaves. Since the cited gel studies utilised polar solvents, prepare ethanolic or hydroethanolic extracts [32, 34, 35]. Standardise using HPLC fingerprinting for vitexin and isovitexin as well as total phenolic and flavonoid levels [28, 29].
Stage 2: The extract is screened in vitro.Antioxidant tests using DPPH and ABTS [29]Aminoguanidine is used as a positive control in BSA-glucose, BSA-fructose, and BSA-MGO glycation experiments [1,12,19]. Measure fluorescent AGEs using protein carbonyl, fructosamine, and CML as supportive endpoints [19].
Optional skin-enzyme assays (elastase, collagenase, tyrosinase), which are used to profile cosmeceutical plant extracts [40].
Safety screening is the third stage. Fibroblast or keratinocyte cytotoxicity; irritating constituent screening; and subsequently a skin irritation investigation [32]. Hydrogel formulation is the fourth stage. Choose a biocompatible gelling polymer from those listed in the literature on cosmetic hydrogels [38, 39]. Make gels that are both blank and loaded with extract at various extract strengths. A beginning range of 10–20% extract [34] and 100 mg/mL extract [35] were employed in earlier Jatropha gel studies.

Stage 5: Physicochemical analysis. appearance, colour, smell, homogeneity, storage stability, and spreadability [32, 35, 36]. Since delivery is dependent on the skin barrier and the carrier, including extract content (marker chemicals) and release or permeation testing [38].

Stage 6: The gel's effectiveness. On the prepared gel, repeat the glycation tests in comparison to the blank base. Extend to glycated fibroblast or reconstructed-skin models when facilities permit, and eventually assess skin autofluorescence in human research [1].

10. Research Gaps and Future Directions

1. No Jatropha species have direct anti-glycation data (the main gap found here). 2. Inconsistent species identification across studies and a lack of standardised leaf . 3. It is necessary to determine whether activity results from dicarbonyl trapping. 4. There is a dearth of safety information about the topical application of leaf extracts. It is necessary to rule out latex contamination and irritating diterpenes. 5. Skin models have not been used to test current Jatropha gels for AGE-related outcomes. 6. Since there is little clinical evidence for anti-glycation cosmeceuticals in general [1,4], any new product would require carefully planned human investigations.

CONCLUSION

Plant polyphenols are attractive, seemingly harmless anti-glycation possibilities. Glycation is known to contribute to skin ageing. Jatropha leaves exhibit potent antioxidant activity, include flavone C-glycosides such vitexin and isovitexin, and have been developed into topical gels with anti-inflammatory and wound-healing properties. When taken as a whole, these results provide a solid scientific foundation for researching a hydrogel made from Jatropha leaf extract as an anti-glycation cosmeceutical. The genus's toxicity profile necessitates cautious safety work, and the anti-glycation activity itself has not yet been tested. A useful path for experimental verification is provided by the suggested framework.

REFERENCES

Choi JY, Ha NG, Lee WJ, Boo YC. Synthetic and natural agents targeting advanced glycation end-products for skin anti-aging: a comprehensive review of experimental and clinical studies. Antioxidants. 2025;14 (4):498. doi:10.3390/antiox14040498
Zhao C, Wang L, Jiang Y. The effects of advanced glycation end-products on skin and potential anti-glycation strategies. Exp Dermatol. 2024;33 (4):e15065.
Gkogkolou P, Böhm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4 (3):259–270.
Haykal D. Skin glycomics: unmasking the role of glycation end products in cutaneous aging and dermatology. J Cosmet Dermatol. 2026.
Uceda AB, Mariño L, Casasnovas R, Adrover M. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition. Biophys Rev. 2024;16:189–218.
Twarda-Clapa A, Olczak A, Bia?kowska AM, Kozio?kiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312.
Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18:1–14.
Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006;126:291–299.
Masaki H, Okano Y, Sakurai H. Generation of active oxygen species from advanced glycation end-products (AGE) under ultraviolet light A (UVA) irradiation. Biochem Biophys Res Commun. 1997;235:306–310.
Chinchansure AA, Korwar AM, Kulkarni MJ, Joshi SP. Recent development of plant products with anti-glycation activity: a review. RSC Adv. 2015;5 (39):31113–31138.
Sadowska-Bartosz I, Bartosz G. Prevention of protein glycation by natural compounds. Molecules. 2015;20 (2):3309–3334.
Sadowska-Bartosz I, Galiniak S, Bartosz G. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Molecules. 2014;19 (11):18828–18849.
Harris CS, Beaulieu LP, Fraser MH, et al. Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity. Planta Med. 2011;77:196–204.
Peng X, Zheng Z, Cheng KW, et al. Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts. Food Chem. 2008;106:475–481.
Lan MY, Li HM, Tao G, et al. Effects of four bamboo derived flavonoids on advanced glycation end products formation in vitro. J Funct Foods. 2020;71:103976.
Kim JM, Jang DS, Lee YM, et al. Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha. Chem Biodivers. 2008;5 (2).
Multifaceted biological activity of selected flavone C-monoglucosides. Int J Mol Sci. 2025;26 (20):10124. doi:10.3390/ijms262010124
Water extract of mungbean (Vigna radiata L.) inhibits protein tyrosine phosphatase-1B in insulin-resistant HepG2 cells. Molecules. 2021;26 (5):1452.
Nunthanawanich P, Sompong W, Sirikwanpong S, Mäkynen K, Adisakwattana S, Dahlan W, Ngamukote S. Moringa oleifera aqueous leaf extract inhibits reducing monosaccharide-induced protein glycation and oxidation of bovine serum albumin. SpringerPlus. 2016;5:1098.
Rodrigues WD, Cardoso FN, Baviera AM, dos Santos AG. In vitro antiglycation potential of erva-baleeira (Varronia curassavica Jacq.). Antioxidants. 2023;12 (2):522. doi:10.3390/antiox12020522
Sabandar CW, Ahmat N, Jaafar FM, Sahidin I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): a review. Phytochemistry. 2013;85:7–29. doi:10.1016/j.phytochem.2012.10.009
Abdelgadir HA, Van Staden J. Ethnobotany, ethnopharmacology and toxicity of Jatropha curcas L. (Euphorbiaceae): a review. S Afr J Bot. 2013;88:204–218.
Laxane SN, Swarnkar S, Mruthunjaya K, Zanwar SB, Manjunath Setty M. Jatropha curcas: a systemic review on pharmacological, phytochemical, toxicological profiles and commercial applications. Res J Pharm Biol Chem Sci. 2013;4 (1):989–1010.
Félix-Silva J, Giordani RB, Silva-Jr AA, Zucolotto SM, Fernandes-Pedrosa MF. Jatropha gossypiifolia L. (Euphorbiaceae): a review of traditional uses, phytochemistry, pharmacology, and toxicology of this medicinal plant. Evid Based Complement Alternat Med. 2014;2014:369204. doi:10.1155/2014/369204
Wu Q, Pato?ka J, Nepovimova E, Kuca K. Jatropha gossypiifolia L. and its biologically active metabolites: a mini review. J Ethnopharmacol. 2019;234:197–203.
Félix-Silva J, et al. In vitro anticoagulant and antioxidant activities of Jatropha gossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical applications. BMC Complement Altern Med. 2014;14:405. doi:10.1186/1472-6882-14-405
Félix-Silva J, et al. Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom. PLoS ONE. 2014;9 (8):e104952.
Papalia T, Barreca D, Panuccio MR. Assessment of antioxidant and cytoprotective potential of jatropha (Jatropha curcas) grown in Southern Italy. Int J Mol Sci. 2017;18 (3):660.
Huang Q, Guo Y, Fu R, Peng T, Zhang Y, Chen F. Antioxidant activity of flavonoids from leaves of Jatropha curcas. ScienceAsia. 2014;40:193–197.
Islam M, et al. Biological investigation of Jatropha gossypiifolia: a stiff medicinal plant in Bangladesh. Iran J Pharm Sci. 2017.
Gabriel BO, Idu M. Anti-diuretic and anti-glycemic properties of Jatropha gossypiifolia L. leave extract on Wistar rats. Clin Phytosci. 2021;7. doi:10.1186/s40816-021-00329-6
Passos JGR, Gomes JAS, Xavier-Santos JB, et al. Anti-inflammatory, healing and antiophidic potential of Jatropha mollissima (Pohl) Baill. (Euphorbiaceae): from popular use to pharmaceutical formulation in gel. Biomed Pharmacother. 2024;173:116290. doi:10.1016/j.biopha.2024.116290
Alzomor AK, Sallam NM, Al-Fotaihy SA, Al-Moliki B, Al-Zohairy BA. Antibacterial and wound healing activities of topical gel of Jatropha variegata Vahl extract in rats. Pharm Biomed Res. 2020;6 (4):287–296. doi:10.18502/pbr.v6i4.5115
Mesak I, Christina OD, T.I. A. Effectiveness test of gel formulation of Jatropha curcas L extract as a burn healing in white male Wistar rat. J Farm Sains Indones. 2024;7 (1):172–178. doi:10.52216/jfsi.vol7no1p172-178
Margaretha EV, Wirasisya DG, Juliantoni Y. Antibacterial activities from gel hand sanitizer of Jatropha curcas leaves ethanolic extract against Staphylococcus aureus ATCC 25923. Sasambo J Pharm. 2020.
Siswati S, Aryati F, Narsa AC. Formulation of hand sanitizer gel jatropha sap (Jatropha curcas L) as antiseptic. J Trop Pharm Chem. 2022.
IPCS INCHEM. Poisons Information Monograph: Jatropha curcas L. Available at: inchem.org/documents/pims/plant/jcurc.htm
Zagórska-Dziok M, Sobczak M. Hydrogel-based active substance release systems for cosmetology and dermatology application: a review. Pharmaceutics. 2020;12 (5):396.
Mitura S, Sionkowska A, Jaiswal A. Biopolymers for hydrogels in cosmetics: review. J Mater Sci Mater Med. 2020;31 (6):50. doi:10.1007/s10856-020-06390-w
Andrade JM, Domínguez-Martín EM, et al. Screening the dermatological potential of Plectranthus species components: antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase. J Enzyme Inhib Med Chem. 2021. doi:10.1080/14756366.2020.1862099

Reference

Choi JY, Ha NG, Lee WJ, Boo YC. Synthetic and natural agents targeting advanced glycation end-products for skin anti-aging: a comprehensive review of experimental and clinical studies. Antioxidants. 2025;14 (4):498. doi:10.3390/antiox14040498
Zhao C, Wang L, Jiang Y. The effects of advanced glycation end-products on skin and potential anti-glycation strategies. Exp Dermatol. 2024;33 (4):e15065.
Gkogkolou P, Böhm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4 (3):259–270.
Haykal D. Skin glycomics: unmasking the role of glycation end products in cutaneous aging and dermatology. J Cosmet Dermatol. 2026.
Uceda AB, Mariño L, Casasnovas R, Adrover M. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition. Biophys Rev. 2024;16:189–218.
Twarda-Clapa A, Olczak A, Bia?kowska AM, Kozio?kiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312.
Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18:1–14.
Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006;126:291–299.
Masaki H, Okano Y, Sakurai H. Generation of active oxygen species from advanced glycation end-products (AGE) under ultraviolet light A (UVA) irradiation. Biochem Biophys Res Commun. 1997;235:306–310.
Chinchansure AA, Korwar AM, Kulkarni MJ, Joshi SP. Recent development of plant products with anti-glycation activity: a review. RSC Adv. 2015;5 (39):31113–31138.
Sadowska-Bartosz I, Bartosz G. Prevention of protein glycation by natural compounds. Molecules. 2015;20 (2):3309–3334.
Sadowska-Bartosz I, Galiniak S, Bartosz G. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Molecules. 2014;19 (11):18828–18849.
Harris CS, Beaulieu LP, Fraser MH, et al. Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity. Planta Med. 2011;77:196–204.
Peng X, Zheng Z, Cheng KW, et al. Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts. Food Chem. 2008;106:475–481.
Lan MY, Li HM, Tao G, et al. Effects of four bamboo derived flavonoids on advanced glycation end products formation in vitro. J Funct Foods. 2020;71:103976.
Kim JM, Jang DS, Lee YM, et al. Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha. Chem Biodivers. 2008;5 (2).
Multifaceted biological activity of selected flavone C-monoglucosides. Int J Mol Sci. 2025;26 (20):10124. doi:10.3390/ijms262010124
Water extract of mungbean (Vigna radiata L.) inhibits protein tyrosine phosphatase-1B in insulin-resistant HepG2 cells. Molecules. 2021;26 (5):1452.
Nunthanawanich P, Sompong W, Sirikwanpong S, Mäkynen K, Adisakwattana S, Dahlan W, Ngamukote S. Moringa oleifera aqueous leaf extract inhibits reducing monosaccharide-induced protein glycation and oxidation of bovine serum albumin. SpringerPlus. 2016;5:1098.
Rodrigues WD, Cardoso FN, Baviera AM, dos Santos AG. In vitro antiglycation potential of erva-baleeira (Varronia curassavica Jacq.). Antioxidants. 2023;12 (2):522. doi:10.3390/antiox12020522
Sabandar CW, Ahmat N, Jaafar FM, Sahidin I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): a review. Phytochemistry. 2013;85:7–29. doi:10.1016/j.phytochem.2012.10.009
Abdelgadir HA, Van Staden J. Ethnobotany, ethnopharmacology and toxicity of Jatropha curcas L. (Euphorbiaceae): a review. S Afr J Bot. 2013;88:204–218.
Laxane SN, Swarnkar S, Mruthunjaya K, Zanwar SB, Manjunath Setty M. Jatropha curcas: a systemic review on pharmacological, phytochemical, toxicological profiles and commercial applications. Res J Pharm Biol Chem Sci. 2013;4 (1):989–1010.
Félix-Silva J, Giordani RB, Silva-Jr AA, Zucolotto SM, Fernandes-Pedrosa MF. Jatropha gossypiifolia L. (Euphorbiaceae): a review of traditional uses, phytochemistry, pharmacology, and toxicology of this medicinal plant. Evid Based Complement Alternat Med. 2014;2014:369204. doi:10.1155/2014/369204
Wu Q, Pato?ka J, Nepovimova E, Kuca K. Jatropha gossypiifolia L. and its biologically active metabolites: a mini review. J Ethnopharmacol. 2019;234:197–203.
Félix-Silva J, et al. In vitro anticoagulant and antioxidant activities of Jatropha gossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical applications. BMC Complement Altern Med. 2014;14:405. doi:10.1186/1472-6882-14-405
Félix-Silva J, et al. Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom. PLoS ONE. 2014;9 (8):e104952.
Papalia T, Barreca D, Panuccio MR. Assessment of antioxidant and cytoprotective potential of jatropha (Jatropha curcas) grown in Southern Italy. Int J Mol Sci. 2017;18 (3):660.
Huang Q, Guo Y, Fu R, Peng T, Zhang Y, Chen F. Antioxidant activity of flavonoids from leaves of Jatropha curcas. ScienceAsia. 2014;40:193–197.
Islam M, et al. Biological investigation of Jatropha gossypiifolia: a stiff medicinal plant in Bangladesh. Iran J Pharm Sci. 2017.
Gabriel BO, Idu M. Anti-diuretic and anti-glycemic properties of Jatropha gossypiifolia L. leave extract on Wistar rats. Clin Phytosci. 2021;7. doi:10.1186/s40816-021-00329-6
Passos JGR, Gomes JAS, Xavier-Santos JB, et al. Anti-inflammatory, healing and antiophidic potential of Jatropha mollissima (Pohl) Baill. (Euphorbiaceae): from popular use to pharmaceutical formulation in gel. Biomed Pharmacother. 2024;173:116290. doi:10.1016/j.biopha.2024.116290
Alzomor AK, Sallam NM, Al-Fotaihy SA, Al-Moliki B, Al-Zohairy BA. Antibacterial and wound healing activities of topical gel of Jatropha variegata Vahl extract in rats. Pharm Biomed Res. 2020;6 (4):287–296. doi:10.18502/pbr.v6i4.5115
Mesak I, Christina OD, T.I. A. Effectiveness test of gel formulation of Jatropha curcas L extract as a burn healing in white male Wistar rat. J Farm Sains Indones. 2024;7 (1):172–178. doi:10.52216/jfsi.vol7no1p172-178
Margaretha EV, Wirasisya DG, Juliantoni Y. Antibacterial activities from gel hand sanitizer of Jatropha curcas leaves ethanolic extract against Staphylococcus aureus ATCC 25923. Sasambo J Pharm. 2020.
Siswati S, Aryati F, Narsa AC. Formulation of hand sanitizer gel jatropha sap (Jatropha curcas L) as antiseptic. J Trop Pharm Chem. 2022.
IPCS INCHEM. Poisons Information Monograph: Jatropha curcas L. Available at: inchem.org/documents/pims/plant/jcurc.htm
Zagórska-Dziok M, Sobczak M. Hydrogel-based active substance release systems for cosmetology and dermatology application: a review. Pharmaceutics. 2020;12 (5):396.
Mitura S, Sionkowska A, Jaiswal A. Biopolymers for hydrogels in cosmetics: review. J Mater Sci Mater Med. 2020;31 (6):50. doi:10.1007/s10856-020-06390-w
Andrade JM, Domínguez-Martín EM, et al. Screening the dermatological potential of Plectranthus species components: antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase. J Enzyme Inhib Med Chem. 2021. doi:10.1080/14756366.2020.1862099

Sagar Vaidya

Corresponding author

Assistant professor , JES SND institute of pharmacy Babhulgaon Yeola -423401